Antioxidant anti-inflammatory treatment in type 2 diabetes

Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S232-6. doi: 10.2337/dc09-S316.

Authors

Antonio Ceriello¹, Roberto Testa

Affiliation

¹ Centre of Excellence in Diabetes and Endocrinology, University Hospital of Coventry and Warwickshire, Warwick Medical School, University of Warwick, Coventry, U.K. Antonio Ceriello, antonio.ceriello@warwick.ac.uk

No abstract available

Publication types

Review

MeSH terms

Anti-Inflammatory Agents / therapeutic use*
Antioxidants / therapeutic use*
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / physiopathology
Diabetic Angiopathies / prevention & control
Humans
Hyperglycemia / physiopathology
Nitric Oxide / metabolism
Nitric Oxide Synthase Type II / metabolism
Nitric Oxide Synthase Type III / metabolism
Oxidative Stress / drug effects
Oxidative Stress / physiology*

Substances

Anti-Inflammatory Agents
Antioxidants
Nitric Oxide
Nitric Oxide Synthase Type II
Nitric Oxide Synthase Type III